Alterola Biotech Inc
OTC:ABTI

Watchlist Manager
Alterola Biotech Inc Logo
Alterola Biotech Inc
OTC:ABTI
Watchlist
Price: 0.0051 USD Market Closed
Market Cap: $7.4m

Alterola Biotech Inc
Capital Expenditures

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Alterola Biotech Inc
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Alterola Biotech Inc
OTC:ABTI
Capital Expenditures
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Estee Lauder Companies Inc
NYSE:EL
Capital Expenditures
-$533m
CAGR 3-Years
19%
CAGR 5-Years
2%
CAGR 10-Years
0%
Bellring Brands Inc
NYSE:BRBR
Capital Expenditures
-$7.6m
CAGR 3-Years
-72%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Coty Inc
NYSE:COTY
Capital Expenditures
-$215m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inter Parfums Inc
NASDAQ:IPAR
Capital Expenditures
-$48.2m
CAGR 3-Years
29%
CAGR 5-Years
-31%
CAGR 10-Years
9%
elf Beauty Inc
NYSE:ELF
Capital Expenditures
-$31.6m
CAGR 3-Years
-157%
CAGR 5-Years
-38%
CAGR 10-Years
-12%
No Stocks Found

Alterola Biotech Inc
Glance View

Market Cap
7.4m USD
Industry
Consumer products

Alterola Biotech, Inc. develops medical cannabis products. The company is headquartered in Walnut, California. The company went IPO on 2010-03-09. The firm is focused on developing pharmaceutical medicines made from cannabinoid, cannabinoid-like and non-cannabinoid active pharmaceutical ingredients (APIs) globally. The company is also focused on developing non-pharmaceutical (nutraceutical / dietary supplement) products containing cannabinoids, cannabinoid-like and non-cannabinoid food-grade ingredients. In addition, the Company is focused on supplying cosmetic ingredients to potential customers who develops products containing cannabinoids, cannabinoid-like and non-cannabinoid ingredients.

ABTI Intrinsic Value
Not Available

See Also

What is Alterola Biotech Inc's Capital Expenditures?
Capital Expenditures
0 USD

Based on the financial report for Jun 30, 2024, Alterola Biotech Inc's Capital Expenditures amounts to 0 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett